| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355633 Contraceptives |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/07/2002 | WO2002018540A2 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | WO2002018330A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 03/07/2002 | WO2002018329A1 Acetylenic sulfonamide derivatives |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001085680A3 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
| 03/07/2002 | US20020028401 Use of iron azo complex compounds as charge control agents |
| 03/07/2002 | DE10040783A1 AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) AZA-amino acid derivatives (factor inhibitors X¶a¶ 15) |
| 03/07/2002 | CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | CA2419841A1 Novel cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/06/2002 | EP1184370A2 Compounds with growth hormone releasing properties |
| 03/06/2002 | EP1183240A1 Beta2-adrenoceptor agonists |
| 03/06/2002 | EP1183236A1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183232A2 Monofluoroalkyl derivatives |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016317A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2001079162A3 INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 02/28/2002 | WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 02/28/2002 | WO2001068593A3 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 02/28/2002 | US20020026065 2-hydroxy-3 - (4-hydroxy-3-sulfonamidophenyl) - propylamines useful as beta 3 adrenergic agonists |
| 02/28/2002 | US20020026021 Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts |
| 02/28/2002 | US20020025947 Serine protease inhibitor |
| 02/28/2002 | US20020025934 Renin inhibitor |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/27/2002 | EP1181271A2 Naphthalene ureas as glucose uptake enhancers |
| 02/27/2002 | EP1181270A2 Inhibitors of factor xa |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/26/2002 | US6350905 Catalytic reaction of olefin in the presence of osmium catalyst for aminohydroxylation |
| 02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 02/26/2002 | US6350778 Cardiovascular disorders |
| 02/26/2002 | US6350545 Battery electrolyte |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014262A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 02/21/2002 | WO2002014259A1 Calcium receptor antagonists |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | US20020022738 Solubility makes it possible to manufacture a solution of higher concentration of the compound and high-dosage drug product |
| 02/21/2002 | US20020022659 For therapy of viral infection |
| 02/21/2002 | US20020022647 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/19/2002 | US6348614 Aminobutyric acid fungicides |
| 02/19/2002 | US6348504 Oxime ethers as IIb/IIa antagonists |
| 02/19/2002 | US6348499 Amphiphilic polyamide compounds |
| 02/19/2002 | US6348476 Ion exchange inhibitor for cardiovascular disorders |
| 02/19/2002 | US6348448 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 02/14/2002 | WO2002012181A1 Novel diamines having a casr modulating activity |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | DE10036184A1 Substituierte Sulfonylaminomethylbenzoesäure(derivate) und Verfahren zu ihrer Herstellung Substituted Sulfonylaminomethylbenzoesäure (derivatives) and processes for their preparation |
| 02/14/2002 | CA2415467A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/13/2002 | EP1179530A1 Processes for preparing optically active amino acid derivatives |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP0699069B1 Endothelin receptor antagonists |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | CA2048139C N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 02/07/2002 | WO2002009688A1 Fatty acid synthase inhibitors |
| 02/07/2002 | WO2002009686A2 Cdc25 phosphatase inhibitors |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016350 Useful in treatment of diseases or conditions associated with erythropoietin receptor |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020015826 Zwitterionic iodonium compounds and methods of application |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | DE10036852A1 Urethanderivate Urethane |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | CA2417262A1 Cdc25 phosphatase inhibitors |
| 02/06/2002 | EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177170A1 Fluoroalkanesulfonylazide monomers and copolymers thereof |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | EP0790824B1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1078885C Process for nitrating diphenyl ether compounds |
| 02/05/2002 | US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |